Abstract.
The present study was undertaken to determine whether improvement of hyperglycemia alters calcium and phosphorus handling, parathyroid hormone (PTH) secretion and bone turnover in patients with non-insulin-dependent diabetes mellitus (NIDDM).
We measured serum and urinary mineral levels, serum intact PTH and osteocalcin on admission and at discharge (38 ± 3 days later, Means ± SEM) in 28 patients with poorly-controlled NIDDM (63 ± 2 years old, 13 males and 15 females [4, 5] . An increased concentration of parathyroid hormone-related peptide may play a compensatory role in calcium homeostasis in patients with non-insulin-dependent diabetes mellitus (NIDDM) [6] . With respect to bone metabolism, histomorphometric studies have shown that bone turnover is low in diabetic animals [7, 8] . Also, serum osteocalcin concentrations are low in diabetic animals and human patients [7] [8] [9] [10] . Urinary loss of minerals can be corrected by appropriate blood glucose control [11] [12] [13] , but it remains unclear whether glycemic control has any effect on PTH secretion or bone turnover. The present study 
Subjects and Methods
Twenty-eight diabetic patients (13 males and 15 females) with a mean age of 63 ± 2 years were studied at Tokyo Metropolitan Komagome Hospital from 1991 to 1993. Only one premenopausal female was included.
Their Body Mass Index was 22.8 ± 0.7 on admission.
They were admitted because of hyperglycemia and diagnosed as having NIDDM, based on their typical clinical courses and urinary C-peptide excretion (23.6 ± 3.2 nmol/day) [14] . Gastrectomized patients and patients with liver diseases, endocrine disorders and those taking drugs affecting bone metabolism were all excluded.
Serum creatinine concentrations were below 106 umol/l in all the patients.
Diabetic retinopathy was present in 13 of them, urinary albumin excretion exceeded 30 mg/day in 14 and Achilles tendon reflex was absent in 13. At discharge, 8 patients were treated with diet therapy alone, 10 with sulf onylurea and 10 with insulin. Among 10 insulin-treated patients, 6 patients were newly introduced to insulin therapy. During the hospitalization period, they were given 30 kcal diet per kg of their ideal body weight, containing mean levels of 660 mg calcium, 1130 mg phosphorus and 210 mg magnesium per day. As exercise, they continued walking of 10,000 paces as much as possible. All the patients gave their informed consent to the present study.
On day 2 or 3 of the hospitalization and 3 or 4 days before discharge (38 ± 3 days after the admission), blood samples were taken after an overnight fast to measure plasma glucose, HbA1c, serum calcium, phosphorus, magnesium, creatinine, intact PTH, 1, 25 dihydroxycholecalciferol (1, 25(OH)2D3), alkaline-phosphatase, leucine amino peptidase and osteocalcin.
On the same days as blood sampling, 24-h urine collection was done to measure the daily excretion of calcium, phosphorus, magnesium, creatinine, glucose and C-peptide.
Plasma and urinary glucose concentrations were measured by the glucose-oxidase method, and HbA1c by HPLC [15] . Serum and urinary calcium, phosphorus, magnesium, creatinine and serum leucine amino peptidase concentrations were measured with an automatic clinical analyzer (Model 736, Hitachi Co., Katsuta, Japan). Serum total alkaline-phosphatase was measured by the method using paranitrophenyl phosphate [16] . Serum intact PTH and osteocalcin levels were measured with immunoradiometric assay kits (Baxter Co. and Mitsubishi Yuka Co., Tokyo, Japan) [17, 18] . Serum 1, 25(OH)2D3 concentrations were measured by a radioreceptor assay [19] . Urinary C-peptide levels were measured with a radioimmunoassay kit (Daiichi-Radioisotope Co., Tokyo, Japan) [20] .
The intra-and inter-assay coefficients of variation were 2.6% and 5.8% for intact-PTH, 6.3% and 5.7% for osteocalcin, 7.7% and 7.6% for 1, 25(OH)2D3, and 5.7% and 3.5% for C-peptide, respectively. Serum calcium values (mmol/l) in this paper were converted from the corrected values for calcium (mg/dl); the corrected values for calcium = the measured values for calcium (mg/dl) + 4 -the values for serum albumin (g/dl) [21] . The renal threshold for phosphorus excretion was obtained from the nomogram by Walton [22] . Data are presented as the Means ± SEM. Statistical analysis was performed by using Student's paired t-test and Pearson's correlation coefficient. A P value of less than 0.05 was considered to be significant. Tables 11-3 show the parameters measured on admission and at discharge.
Results
There was significant reduction in fasting plasma glucose, HbA1c and urinary glucose excretion after the induction of appropriate therapies during the hospitalization. Urinary C-peptide excretion did not show a significant change.
Serum calcium concentrations remained unchanged, while serum phosphorus rose significantly.
Serum magnesium concentrations were slightly but significantly elevated (Table  1) . There was a significant decrease in the ratios of urinary calcium and phosphorus to creatinine, as well as the daily excretion of both minerals. Urinary magnesium excretion did not change. The renal threshold for phosphorus excretion rose significantly ( (Table 3) . On admission, urinary calcium and phosphorus excretion showed a positive correlation with urinary glucose excretion (Fig. 1) . Serum calcium correlation with the renal threshold for phosphorus excretion (Fig. 3) . Serum osteocalcin levels were neither correlated with serum alkaline-phosphatase (r=0.36, P>0.05) nor with the ratio of urinary calcium to creatinine (r=0.34, P>0.05).
Discussion
In the present study, we compared several parameters of bone and mineral metabolism in patients with poorly-controlled NIDDM to those after they achieved improved glycemic control. Our results revealed that urinary excretion of calcium and phosphorus increased relatively when the patients were poor in metabolic control. The enhanced urinary loss of calcium and phosphorus, related to urinary glucose excretion [11] [12] [13] , became reduced in parallel with the improvement in glycemic control. The lowered serum phosphorus levels on admission were d ue to urinary loss of phosphorus, since they were positively correlated with the renal threshold for phosphorus excretion. Serum magnesium concentrations increased significantly, but remained within the normal range. Urinary magnesium excretion also remained within the normal range.
It seems that there was no magnesium deficiency in our diabetic patients.
In general, plasma levels of PTH have been reported to be low or low-normal in patients with diabetes mellitus [4] [5] [6] 23] . Low-normal PTH concentrations after the achievement of glycemic control in the present study were consistent with previous reports, but we demonstrated that PTH concentrations were slightly but significantly higher in the hyperglycemic state than those in the improved glycemic state. Serum 1, 25(OH)2D3 concentrations did not change in accordance with intact PTH. The low or low-normal levels of active vitamin D suggest that intestinal calcium absorption was diminished in the subjects studied. Also, the decreased active vitamin D concentrations may contribute in part to the low-normal serum osteocalcin, since 1, 25(OH)2D3 is known to stimulate osteocalcin synthesis in the osteoblast-like cell line [24] .
Serum alkaline-phosphatase and osteocalcin are markers of bone formation [25] . Osteocalcin is also a marker of bone turnover, when bone formation and resorption are coupled [25] . An increase in serum alkaline-phosphatase, derived from bone, is frequently found in diabetic patients [26, 27] , but in the present study serum leucine amino peptidase also decreased after glycemic control. It is not concluded that the decrease in serum total alkaline-phosphatase was due to the change in its iso-enzyme from bone. Low-normal osteocalcin, observed in our diabetic patients, was consistent with previous reports [9, 10] . The function of osteoblasts is suppressed in diabetic animals and human patients [7] [8] [9] [10] . After glycemic control, serum osteocalcin increased in spite of the decrease in serum intact PTH. As PTH stimulates bone turnover by directly acting on osteoblasts [28] , the response of osteoblasts to PTH may be impaired in the hyperglycemic state. On the other hand, insulin has an anabolic effect on osteoblasts [29] . Urinary C-peptide excretion did not change during the hospitalization period. Insulin therapy was newly introduced in some of the patients. The improvement in insulin sensitivity and adequate supplement of insulin might have a beneficial effect on the function of osteoblasts.
The association between serum calcium and PTH concentrations seems to have been well maintained in our diabetic patients. Both serum PTH levels and urinary calcium excretion decreased with the improvement in glycemic control. Therefore, urinary calcium loss, associated with glycosuria, seems to stimulate PTH secretion in the hyperglycemic 
